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Hypertension and ischemia :
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ALAN N. GRADMAN, MD, FACC
Pittsburgh, Perrn.r_lrtnda
The determinants of myocardial ischemia in patients with
hypertension are of intense investigative interest . It is well
established that hypertension is a major risk factor for
coronary atherosclerosis and acute myocardial infarction .
The
early
observation (1,2) that infarction was more likely to
be lethal in hypertensive patients pointed en the probability
that additional factors are operative in the pathogenesis of
myocardial ischemic syndromes in hypertension . It has also
been suggested (3,4) that ischemia may he important in the
development of chronic left ventricular dysfunction and
ventricular arrhythmias characteristic of hypertensive heart
disease . In addition, it is now recognized that some hyper-
tensive patients exhibit angina pectoris and demonstrable
myocardial ischemia in the absence of significant large vessel
coronary obstruction .
Relation between myocardial hypertrophy and ischemia.
The recognition that left ventricular hypertrophy is an inde-
pendent risk factor for the development of clinical coronary
artery disease (5) focused attention on the relation between
myocardial hypertrophy and myocardial ischemia . Clinical
and experimental studies document that coronary flow re-
serve-the maximal increase in blood flow attainable
through pharmacologic coronary vasodilation-is markedly
reduced in the hypertrophied ventricle
(4,6) ; additional data
(7) document an increased susceptibility to ischemic dam-
age, In one interesting series of studies (3,8) using a canine
model of myocardial infarction, both infarct size and the
frequency of arrhythmic death were greater in dogs with
hypertension and left ventricular hypertrophy than in control
animals . It was postulated that decreased capillary density
and extravascalar compressive forces predispose the hyper-
trophied ventricle to ischemic damage .
At the same time, there has been increasing recognition of
the rule of the vasculature itself in the pathuphysiotugy of
ischemia in hypertension . It is clear that hypertrophy occurs
in vascular smooth muscle as well as in the myncardhlm. and
that the medial layer of coronary arteries is thickened in
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hypertensive animals and humans (9). For geometric rea-
sons, the direct consequences of medial hypertrophy include
a disproportionate reduction in luminal diameter in response
to any vasncnnstrictive stimulus . The result is an abnormal
increase in coronary vascular resistance under a variety of
circumstances .
Role of abnormal coronary vasculature in myocardial
ischemia . The independent role of the vascttlantre in pro-
ducing myocardial ischemia was further defined in a report
by Brush ct al. (10) in which abnormal coronary blood flow
was documented in hypertensive patients without evidence
of left ventricular hypertrophy or coronary artery disease .
These patients had symptoms suggestive of angina and these
symptoms could be reproduced by rapid atrial pacing, Basal
coronary blood flow was similar to that of control subjects,
but at, attenuated coronary vasodilatory response to
trial
pacing was noted. In addition. there was evidence of an
abnormal vasoconstrictor response to ergonovine,
Role of coronary endothelium
. An important advance in
the general understanding of the regulation of vascular tone
has been the recognition of the importance of the endothe-
lium in elaborating vasodilator and vasoconstrictive sub-
stances . The importance of endothelium-dependent relax-
ation factor as a modulator of vascular tone has been
established (11), and abnormalities in endothelial function
have been described in a variety of disease states including
coronary atherosclerosis (12). Studies in animal models
of hypertension have also documented abnormalities in
endothcliam-depcedent vascular relaxation (13,14) and these
observations have recently been extended to humans. Data
derived from forearm blood flow studies (15) suggest that
abnormalities in endothelium-dependent vascular relaxation
are important contributors to the increased systemic vascu-
lar resistance seen in hypertensive patients .
The present study. The study by Brush et al . (16) re-
ported in this issue of the Journal makes a further contribu-
tion to our understanding of coronary blood flow regulation
in patients with hypertension . These investigators docu-
mented a highly abnormal coronary vascular response to the
endothelium-dependent vasodilator acetylcholine in a group
of hypertensive patients with normal coronary arteriogratus.
Using quantitative angiography and direct coronary flow
measurements, the investigators (16) demonstrated an actual
reduction in coronary flow during acetylcholine infusion
in the hypertensive patients compared with the level in con-
trol subjects. In contrast, the vhsadilator response to the
endothelium-independent vasodilator nitroglycerin was pre-
served. These data suggest that in the coronary circulation,
as well as in the periphery, hypertensive patients have
abnormal endothelial function and this abnormality is capa-
ble of impairing coronary perfusion .
The
study has
certain limitations
. A relatively small
number of patients was studied. The unblinded crossover
design raises the possibility of both observer bias and
carryover pharmacologic effects from the first (acetylcho-
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line) to the second (nitroglycerin) injection . It is also difficult
to exclude the possibility that some degree of coronary
atherosclerosis-undetectable by conventional angiogra-
phy-may have been present and contributed to the
ob-
served
abnormality in endothelium-dependent vasudilatian .
Nevertheless, the data are internally consistent and are in
accord with animal studies and with earlier clinical data
documenting similar abnormalities in the peripheral circula-
tion .
Clinical implications. The sum
of
current knowledge sug-
gests that myocardial ischemia in patients with hypertension
has many causes
. Large vessel coronary artery disease is a
critical factor and probably accounts for most episodes of
clinically recognizable myocardial infarction and angina pec-
toris . Other factors that can affect myocardial perfusion-
left ventricular hypertrophy, vascular hypertrophy and
physiologic derangement of coronary blood flow regulation.
including abnormalities of endothelium-dependent vasodila•
Lion-have now been identified . A series of important clin-
ical questions remain . In what way do these "small vessel"
factors affect the size and prognosis of myocardial infarc-
tion? In how many hypertensive patients do these factors
actually cause angina pectoris . and how frequently do they
exacerbate anginal symptoms in patients who also have large
vessel coronary obstruction? What contribution, if any, do
they make to the development of chronic left ventricular
dysfunction and lethal ventricular arrhythmias? How impor-
tant is it to direct antihypenensive drug therapy toward
reversal or attenuation of these newly recognized contribu-
tors to decreased coronary flow?
We now recognize multiple mechanisms by which coro-
nary flow may be impaired in the hypertensive patient . The
contribution of these abnormalities to the clinical manifesta-
tions of hypertensive heart disease remains to be deter-
mined.
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